Actelion says selexipag to enter U.S. market in January

ZURICH (Reuters) - Actelion Ltd, Europe's biggest biotech firm, has won approval from the U.S. Food and Drug Administration to bring a key follow-up to its original lung blockbuster to the American market.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro